Kelly Sweeney

Kelly Sweeney has extensive experience in the pharmaceutical and biotech industry. Kelly has held various roles over the years, starting as a Clinical Sales Specialist at Genentech, where they successfully launched a new thrombolytic product to the cardiology and emergency medicine markets. Kelly then joined Novartis, where they were responsible for launching two products in the oncology market.

Kelly went on to work at Scios Inc., a subsidiary of Johnson & Johnson, as a Hospital Specialist. During their time there, they played a key role in developing a new care set for the treatment of acute decompensated heart failure and received several awards for their performance.

Following their tenure at Scios Inc., Kelly joined Otsuka America Pharmaceutical as a Senior Hospital Specialist. Kelly achieved significant sales growth and received recognition for their formulary wins. Kelly also served as a District Sales Trainer during their time there.

Kelly continued their career at The Medicines Company, first as a Customer Solutions Manager and later as a Regional Business Manager. Kelly was responsible for launching solutions across different disease categories and successfully led a team of hospital specialists. Kelly also exceeded sales goals and played a crucial role in navigating the healthcare system to identify key decision-makers and buyers.

After The Medicines Company, Kelly worked at Chiesi USA as a Regional Business Manager. Kelly successfully managed a team of Hospital Specialists and achieved significant sales growth for the cardiovascular portfolio.

Most recently, Kelly joined Acacia Pharma Inc. as a Hospital Territory Manager, where they were responsible for managing sales in the hospital sector. Currently, they are employed at BioXcel Therapeutics, Inc. as an Institutional Sales employee.

Kelly Sweeney holds a Bachelors of Science degree from the University of Wisconsin-Stout. No specific start or end year for the education is mentioned. The field of study remains unspecified.